Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. scores highest on Torque (62) and lowest on Nitro (13). Its PosiPenta is 33.98 out of 100, weaker than most similar companies.
On the Penta Grid this week, Olema Pharmaceuticals, Inc. is Grid #695 of 837 in the Healthcare sector in United States, and Grid #3,370 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | 33.98 | 35 | 24 | 13 | 62 | 36 |
| Zevra Therapeutics, Inc. | 63.08 | 63 | 58 | 62 | 86 | 46 |
| Gyre Therapeutics, Inc. | 52.87 | 12 | 77 | 57 | 68 | 51 |
| Climb Bio, Inc. | 43.67 | 26 | 35 | 61 | 70 | 27 |
| CorMedix Inc. | 58.56 | 80 | 47 | 50 | 67 | 49 |
| Weave Communications, Inc. | 55.10 | 10 | 79 | 96 | 46 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.10 |
| P/B ratio | 1.34 |
EEarnings
| Trailing EPS | ₹-200.80 |
| Forward EPS | ₹-249.79 |
NNitro
| Price | 623.22 |
| 52-week high | 3434.27 |
| 52-week low | 613.75 |
| Fall from 52-week high | 81.9% |
TTorque
| Return on equity (ROE) | -52.74% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 2.01 |
| Market cap | ₹5,453 Cr |
| Insider holding | 1.76% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Olema Pharmaceuticals, Inc.'s PosiPenta score?
Olema Pharmaceuticals, Inc.'s PosiPenta is 33.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Olema Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Olema Pharmaceuticals, Inc. is Grid #695 of 837 in the Healthcare sector in United States, and Grid #3,370 of 4,000 in United States.
Which PosiPenta pillar is strongest for Olema Pharmaceuticals, Inc.?
Torque (durability), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Olema Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 13 out of 100: much weaker than most similar companies.
Has Olema Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.73 points, from 31.25 to 33.98.
PositoAI is for research and education only and is not investment advice.